October 25, 2019 / 9:02 PM / 19 days ago

GSK wins access to data used in Zofran study funded by plaintiffs' lawyers

GlaxoSmithKline Plc on Friday won access to data underlying a published study funded by plaintiffs lawyers suing the drugmaker, which found a correlation between use of its onetime anti-nausea drug Zofran during pregnancy and birth defects.

U.S. District Judge F. Dennis Saylor during a hearing in Boston ruled the drugmaker could also depose the study’s author for a second time, citing the “unusual set of circumstances” around her peer-reviewed study.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/32PS8qe

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below